Luis David Jiménez‐Franco

Author

ABX-CRO Advanced Pharmaceutical Services (Germany)ORCID

Also Known As

L.D. Jiménez-Franco, Luis David Jimenez-Franco, Luis David Jiménez-Franco, Luis David Jiménez‐Franco, Luis Jiménez-Franco

Publications

605

Citations

H-Index

Concepts

All Affiliations

ABX-CRO Advanced Pharmaceutical Services (Germany)Universität Ulm Heidelberg University University Hospital Heidelberg University Medical Centre Mannheim

About

Luis David Jiménez‐Franco is an author at ABX-CRO Advanced Pharmaceutical Services (Germany) specializing in medicine, systems biology, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	44
2	Health Sciences	1	1	29
3	Cell Biology	1	1	15
4	Orthopaedics	1	1	29
5	Radiation Medicine	1	1	29

Luis David Jiménez‐Franco

Publications

593

Citations

H-Index

Page 1

	Year	Citations
FAPI-74 PET/CT Using Either<sup>18</sup>F-AlF or Cold-Kit<sup>68</sup>Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer Patients Frederik L. Giesel, Sebastian Adeberg, Mustafa Syed, Journal of Nuclear Medicine	2020	282
Biodistribution and dosimetry of a single dose of albumin-binding ligand [177Lu]Lu-PSMA-ALB-56 in patients with mCRPC Vasko Kramer, René Fernández, Wencke Lehnert, European Journal of Nuclear Medicine and Molecular Imaging	2020	66
Phase I study to assess safety, biodistribution and radiation dosimetry for 89Zr-girentuximab in patients with renal cell carcinoma Robin Merkx, Daphne Lobeek, Mark Konijnenberg, European Journal of Nuclear Medicine and Molecular Imaging	2021	66
MITIGATE-NeoBOMB1, a Phase I/IIa Study to Evaluate Safety, Pharmacokinetics, and Preliminary Imaging of <sup>68</sup>Ga-NeoBOMB1, a Gastrin-Releasing Peptide Receptor Antagonist, in GIST Patients Leonhard Gruber, Luis David Jiménez‐Franco, Clemens Decristoforo, Journal of Nuclear Medicine	2020	57
Effect of Tumor Perfusion and Receptor Density on Tumor Control Probability in <sup>177</sup>Lu-DOTATATE Therapy: An In Silico Analysis for Standard and Optimized Treatment Luis David Jiménez‐Franco, Gerhard Glatting, Vikas Prasad, Journal of Nuclear Medicine	2020	32
Treatment planning algorithm for peptide receptor radionuclide therapy considering multiple tumor lesions and organs at risk Luis David Jiménez‐Franco, Peter Kletting, Ambros J. Beer, Medical Physics	2018	29
Evaluation of Safety and Dosimetry of <sup>177</sup>Lu-DOTA-ZOL for Therapy of Bone Metastases René Fernández, Elisabeth Eppard, Wencke Lehnert, Journal of Nuclear Medicine Bone Tumor LesionsOsteoporosisTreatment VerificationOrthopaedic SurgeryBone Disease	2021	29
Automated and robust organ segmentation for 3D-based internal dose calculation Mahmood Nazari, Luis David Jiménez‐Franco, Michael Schroeder, EJNMMI Research	2021	17
Modelling the internalisation process of prostate cancer cells for PSMA-specific ligands Gordon Winter, Anja Vogt, Luis David Jiménez‐Franco, Nuclear Medicine and Biology Prostate Cancer CellsProstatic DiseaseInternalisation ProcessSystems BiologyMedicine	2019	15

Page 1